ROCKET PHARMACEUTICALS, INC.
(RCKT)Financial Statements · SEC EDGAR XBRL
Revenue
$0
Net Income
-$223.1M
+13.8%
EPS
$-2.01
+26.4%
Op. Income
-$231.7M
+15.2%
FCF
-$190.5M
+11.7%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)